Current concept and residual issues of lipoprotein(a) determination for a cardiovascular risk factor
Eur J Clin Invest
.
2022 Jan;52(1):e13700.
doi: 10.1111/eci.13700.
Epub 2021 Nov 8.
Authors
Hiroshi Yoshida
1
2
,
Yuji Hirowatari
3
,
Masatsune Ogura
4
5
,
Mariko Harada-Shiba
5
Affiliations
1
Department of Laboratory Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan.
2
Internal Medicine of Metabolism and Nutrition, The Jikei University Graduate School of Medicine, Minato city, Japan.
3
Department of Health Science, Saitama Prefectural University, Saitama, Japan.
4
Department of General Medical Science, Chiba University Graduate School of Medicine, Chiba, Japan.
5
Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
PMID:
34747007
DOI:
10.1111/eci.13700
No abstract available
Publication types
Editorial
MeSH terms
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / etiology
Dyslipidemias* / complications
Heart Disease Risk Factors
Humans
Lipoprotein(a)
Risk Factors
Substances
Lipoprotein(a)
Grants and funding
26461116/Jikei University Research Fund and Grant-in-Aid for Scientific Research
17K09560/Jikei University Research Fund and Grant-in-Aid for Scientific Research